{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:07:25Z","timestamp":1760144845823,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019211","name":"AbbVie Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol-Myers Squibb Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.cjca.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T11:20:25Z","timestamp":1649848825000},"page":"1244-1252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Statin Use for Primary Cardiovascular Disease Prevention Is Low in Inflammatory Arthritis"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3370-0006","authenticated-orcid":false,"given":"Bindee","family":"Kuriya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadi","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Movahedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob A.","family":"Udell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick R.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward C.","family":"Keystone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Hanneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsie","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula J.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihi","family":"Eder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2022.04.002_bib1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.04.002_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2022.04.002_bib3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/heartjnl-2015-307838","article-title":"Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders","volume":"102","author":"Agca","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2022.04.002_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/acr.22926","article-title":"Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.cjca.2022.04.002_bib5","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1093\/rheumatology\/kez650","article-title":"Amplified prevalence and incidence of cardiovascular disease in patients with inflammatory arthritis and coexistent autoimmune disorders","volume":"59","author":"Heslinga","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cjca.2022.04.002_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3899\/jrheum.180147","article-title":"An update on arthritis in Canada: national and provincial data regarding the past, present, and future","volume":"46","author":"Badley","year":"2019","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cjca.2022.04.002_bib7","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/annrheumdis-2015-207980","article-title":"Incidence and predictors for cardiovascular events in patients with psoriatic arthritis","volume":"75","author":"Eder","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjca.2022.04.002_bib8","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rinc\u00f3n","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2022.04.002_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","article-title":"The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis","volume":"74","author":"Roubille","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjca.2022.04.002_bib10","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.41293","article-title":"Biologics may prevent cardiovascular events in rheumatoid arthritis by inhibiting coronary plaque formation and stabilizing high-risk lesions","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cjca.2022.04.002_bib11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2022.04.002_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170361","article-title":"Metabolic syndrome and its components among rheumatoid arthritis patients: a comprehensive updated systematic review and meta-analysis","volume":"12","author":"Hallajzadeh","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.cjca.2022.04.002_bib13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/acr.22302","article-title":"Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care","volume":"66","author":"Bartels","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.cjca.2022.04.002_bib14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/art.30239","article-title":"Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis","volume":"63","author":"Bartels","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cjca.2022.04.002_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/acr.23094","article-title":"Incidence and management of cardiovascular risk factors in psoriatic arthritis and rheumatoid arthritis: a population-based study","volume":"69","author":"Jafri","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.cjca.2022.04.002_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijcard.2018.06.111","article-title":"Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases","volume":"274","author":"Ikdahl","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2022.04.002_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.reuma.2021.02.002","article-title":"Rheumatoid arthritis, statin indication and lipid goals: analysis according to different recommendations","volume":"18","author":"Masson","year":"2022","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.cjca.2022.04.002_bib18","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/annrheumdis-2013-204024","article-title":"Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis","volume":"74","author":"Arts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjca.2022.04.002_bib19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cjca.2022.04.002_bib20","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/ar2641","article-title":"Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis","volume":"11","author":"Giles","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cjca.2022.04.002_bib21","doi-asserted-by":"crossref","first-page":"n776","DOI":"10.1136\/bmj.n776","article-title":"Role of coronary artery calcium score in the primary prevention of cardiovascular disease","volume":"373","author":"Nasir","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2022.04.002_bib22","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.04.002_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2022.04.002_bib24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3899\/jrheum.150510","article-title":"The Framingham Score and the systematic coronary risk evaluation at low cutoff values are useful surrogate markers of high-risk subclinical atherosclerosis in patients with rheumatoid arthritis","volume":"43","author":"Dessein","year":"2016","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cjca.2022.04.002_bib25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2022.04.002_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/03009742.2019.1600718","article-title":"Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme","volume":"48","author":"Heslinga","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.cjca.2022.04.002_bib27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3899\/jrheum.170379","article-title":"Gaps in diagnosis and treatment of cardiovascular risk factors in patients with psoriatic disease: an international multicenter study","volume":"45","author":"Eder","year":"2018","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cjca.2022.04.002_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/214146","article-title":"GPs' perceptions of cardiovascular risk and views on patient compliance: a qualitative interview study","volume":"2015","author":"Barfoed","year":"2015","journal-title":"Int J Family Med"},{"key":"10.1016\/j.cjca.2022.04.002_bib29","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/acr.22689","article-title":"Rheumatologist and primary care management of cardiovascular disease risk in rheumatoid arthritis: patient and provider perspectives","volume":"68","author":"Bartels","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"7 Suppl","key":"10.1016\/j.cjca.2022.04.002_bib30","first-page":"S35","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Consensus Working Group Update (2016)","volume":"32","author":"Mancini","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2022.04.002_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s13075-021-02617-5","article-title":"Risk of rheumatoid arthritis diagnosis in statin users in a large nationwide US study","volume":"23","author":"Peterson","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cjca.2022.04.002_bib32","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3899\/jrheum.160110","article-title":"Cardiovascular outcomes associated with lowering low-density lipoprotein cholesterol in rheumatoid arthritis and matched nonrheumatoid arthritis","volume":"43","author":"An","year":"2016","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cjca.2022.04.002_bib33","first-page":"296","article-title":"Statin use and mortality in rheumatoid arthritis: an incident user cohort study","volume":"27","author":"Chhibber","year":"2021","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.cjca.2022.04.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105057","article-title":"Effect of statin use on cardiovascular events and all-cause mortality in immune-mediated inflammatory diseases: a systematic review and meta-analysis involving 148,722 participants","volume":"160","author":"Xie","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.cjca.2022.04.002_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107614","article-title":"Statins and autoimmunity: state-of-the-art","volume":"214","author":"Dehnavi","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cjca.2022.04.002_bib36","first-page":"69","article-title":"The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis","volume":"33","author":"Lv","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.cjca.2022.04.002_bib37","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/rheumatology\/keab642","article-title":"The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritis","volume":"61","author":"Karpouzas","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cjca.2022.04.002_bib38","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.04.002_bib39","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2022.04.002_bib40","article-title":"What do US physicians and patients think about lipid-lowering therapy and goals of treatment? Results from the GOULD registry","volume":"10","author":"Arnold","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2022.04.002_bib41","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/acr2.11116","article-title":"Outreach to promote management of cardiovascular risk in primary care among patients with rheumatoid arthritis seen in rheumatology practice","volume":"2","author":"Persell","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.cjca.2022.04.002_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-017-0643-y","article-title":"Managing cardiovascular disease risk in rheumatoid arthritis: clinical updates and three strategic approaches","volume":"19","author":"Chodara","year":"2017","journal-title":"Curr Rheumatol Rep"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X22002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X22002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:48:59Z","timestamp":1760107739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X22002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0828282X22002185"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2022.04.002","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin Use for Primary Cardiovascular Disease Prevention Is Low in Inflammatory Arthritis","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}